KA logo

Kineta, Inc. Common Stock


KA: Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.


Show KA Financials

Consumer Interest
SEC Filings

Recent trades of KA by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by KA's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of KA in WallStreetBets Daily Discussion

KA News

Recent insights relating to KA

CNBC Recommendations

Recent picks made for KA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in KA

Corporate Flights

Flights by private jets registered to KA